212 related articles for article (PubMed ID: 29614639)
1. Microparticles in sickle cell disease.
Romana M; Connes P; Key NS
Clin Hemorheol Microcirc; 2018; 68(2-3):319-329. PubMed ID: 29614639
[TBL] [Abstract][Full Text] [Related]
2. Circulating platelet and erythrocyte microparticles in young children and adolescents with sickle cell disease: Relation to cardiovascular complications.
Tantawy AA; Adly AA; Ismail EA; Habeeb NM; Farouk A
Platelets; 2013; 24(8):605-14. PubMed ID: 23249216
[TBL] [Abstract][Full Text] [Related]
3. Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties.
Garnier Y; Ferdinand S; Garnier M; Cita KC; Hierso R; Claes A; Connes P; Hardy-Dessources MD; Lapouméroulie C; Lemonne N; Etienne-Julan M; El Nemer W; Romana M
Blood; 2020 Jul; 136(2):247-256. PubMed ID: 32285120
[TBL] [Abstract][Full Text] [Related]
4. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
5. Association Between Nitric Oxide, Oxidative Stress, Eryptosis, Red Blood Cell Microparticles, and Vascular Function in Sickle Cell Anemia.
Nader E; Romana M; Guillot N; Fort R; Stauffer E; Lemonne N; Garnier Y; Skinner SC; Etienne-Julan M; Robert M; Gauthier A; Cannas G; Antoine-Jonville S; Tressières B; Hardy-Dessources MD; Bertrand Y; Martin C; Renoux C; Joly P; Grau M; Connes P
Front Immunol; 2020; 11():551441. PubMed ID: 33250889
[TBL] [Abstract][Full Text] [Related]
6. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease.
Nader E; Romana M; Connes P
Front Immunol; 2020; 11():454. PubMed ID: 32231672
[TBL] [Abstract][Full Text] [Related]
7. Erythrocyte microparticles can induce kidney vaso-occlusions in a murine model of sickle cell disease.
Camus SM; Gausserès B; Bonnin P; Loufrani L; Grimaud L; Charue D; De Moraes JA; Renard JM; Tedgui A; Boulanger CM; Tharaux PL; Blanc-Brude OP
Blood; 2012 Dec; 120(25):5050-8. PubMed ID: 22976952
[TBL] [Abstract][Full Text] [Related]
8. Circulating Microparticles in Children With Sickle Cell Anemia in a Tertiary Center in Upper Egypt.
Zahran AM; Elsayh KI; Saad K; Embaby MM; Youssef MAM; Abdel-Raheem YF; Sror SM; Galal SM; Hetta HF; Aboul-Khair MD; Alblihed MA; Elhoufey A
Clin Appl Thromb Hemost; 2019; 25():1076029619828839. PubMed ID: 30740989
[TBL] [Abstract][Full Text] [Related]
9. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasoocclusions in sickle cell disease.
Camus SM; De Moraes JA; Bonnin P; Abbyad P; Le Jeune S; Lionnet F; Loufrani L; Grimaud L; Lambry JC; Charue D; Kiger L; Renard JM; Larroque C; Le Clésiau H; Tedgui A; Bruneval P; Barja-Fidalgo C; Alexandrou A; Tharaux PL; Boulanger CM; Blanc-Brude OP
Blood; 2015 Jun; 125(24):3805-14. PubMed ID: 25827830
[TBL] [Abstract][Full Text] [Related]
10. Differences of microparticle patterns between sickle cell anemia and hemoglobin SC patients.
Garnier Y; Ferdinand S; Etienne-Julan M; Elana G; Petras M; Doumdo L; Tressières B; Lalanne-Mistrih ML; Hardy-Dessources MD; Connes P; Romana M
PLoS One; 2017; 12(5):e0177397. PubMed ID: 28489923
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of circulating blood and endothelial cell microparticles in sickle-cell disease.
Kasar M; Boğa C; Yeral M; Asma S; Kozanoglu I; Ozdogu H
J Thromb Thrombolysis; 2014; 38(2):167-75. PubMed ID: 24254379
[TBL] [Abstract][Full Text] [Related]
12. Red blood cells microparticles are associated with hemolysis markers and may contribute to clinical events among sickle cell disease patients.
Olatunya OS; Lanaro C; Longhini AL; Penteado CFF; Fertrin KY; Adekile A; Saad STO; Costa FF
Ann Hematol; 2019 Nov; 98(11):2507-2521. PubMed ID: 31493004
[TBL] [Abstract][Full Text] [Related]
13. Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD.
Awojoodu AO; Keegan PM; Lane AR; Zhang Y; Lynch KR; Platt MO; Botchwey EA
Blood; 2014 Sep; 124(12):1941-50. PubMed ID: 25075126
[TBL] [Abstract][Full Text] [Related]
14. Oxidative pathways in the sickle cell and beyond.
Alayash AI
Blood Cells Mol Dis; 2018 May; 70():78-86. PubMed ID: 28554826
[TBL] [Abstract][Full Text] [Related]
15. Fetal hemoglobin and hydroxycarbamide moduate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia children.
Nébor D; Romana M; Santiago R; Vachiery N; Picot J; Broquere C; Chaar V; Doumdo L; Odièvre MH; Benkerrou M; Elion J
Haematologica; 2013 Jun; 98(6):862-7. PubMed ID: 23403312
[TBL] [Abstract][Full Text] [Related]
16. Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.
Hierso R; Lemonne N; Villaescusa R; Lalanne-Mistrih ML; Charlot K; Etienne-Julan M; Tressières B; Lamarre Y; Tarer V; Garnier Y; Hernandez AA; Ferracci S; Connes P; Romana M; Hardy-Dessources MD
Br J Haematol; 2017 Mar; 176(5):805-813. PubMed ID: 27984639
[TBL] [Abstract][Full Text] [Related]
17. Hydroxyurea increases plasma concentrations of microparticles and reduces coagulation activation and fibrinolysis in patients with sickle cell anemia.
Brunetta DM; De Santis GC; Silva-Pinto AC; Oliveira de Oliveira LC; Covas DT
Acta Haematol; 2015; 133(3):287-94. PubMed ID: 25472687
[TBL] [Abstract][Full Text] [Related]
18. Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticles.
Jana S; Strader MB; Meng F; Hicks W; Kassa T; Tarandovskiy I; De Paoli S; Simak J; Heaven MR; Belcher JD; Vercellotti GM; Alayash AI
JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385713
[TBL] [Abstract][Full Text] [Related]
19. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.
Shet AS; Aras O; Gupta K; Hass MJ; Rausch DJ; Saba N; Koopmeiners L; Key NS; Hebbel RP
Blood; 2003 Oct; 102(7):2678-83. PubMed ID: 12805058
[TBL] [Abstract][Full Text] [Related]
20. Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study.
Dembélé AK; Lapoumeroulie C; Diaw M; Tessougue O; Offredo L; Diallo DA; Diop S; Elion J; Colin-Aronovicz Y; Tharaux PL; Jouven X; Romana M; Ranque B; Le Van Kim C
Br J Haematol; 2021 Feb; 192(3):634-642. PubMed ID: 33249569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
